Stay updated on Simufilam 100 mg in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.

Latest updates to the Simufilam 100 mg in Alzheimer's Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now loads a 403 Forbidden error screen instead of the study record content, including a 403 text and a Home link. This change means the study details and related sections are not accessible on this page.SummaryDifference18%

- Check14 days agoChange DetectedThe page revision banner updated from v3.6.6 to v3.7.0, indicating a version update with no changes to study details.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This appears to be a minor administrative update to the page version with no changes to the study data or instructions.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page metadata.SummaryDifference0.0%

- Check64 days agoChange DetectedAn updated revision tag appears on the study page, changing from v3.6.3 to v3.6.4. This indicates a minor maintenance update to the ClinicalTrials.gov page rather than a substantive change to the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the study page. This signals a small patch or refinement to the content presentation or functionality without changing the study data.SummaryDifference0.0%

Stay in the know with updates to Simufilam 100 mg in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.